Lanean...

Pharmacological Management of High-risk Neuroblastoma in Children

BACKGROUND: Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Children with high-risk disease have a 3-year event-free survival rate of only 20%. Chemotherapy is the mainstay of the treatment of children with advanced neuroblastom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Paediatr Drugs
Egile Nagusiak: Ganeshan, Veena R., Schor, Nina F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4321778/
https://ncbi.nlm.nih.gov/pubmed/21692548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11591630-000000000-00000
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!